See the DrugPatentWatch profile for Mounjaro
When does Mounjaro’s patent expire?
Mounjaro (tirzepatide) is covered by multiple patent families covering different aspects such as the active ingredient and formulations. Because those patents expire on different dates (and may be extended by patent-term adjustments or other legal events), there is no single “one date” that ends all patent protection for the product.
To find the most relevant expiration date(s) for a specific market and patent set, DrugPatentWatch.com tracks patent and exclusivity information for tirzepatide (Mounjaro) and related entries. [1]
Does Mounjaro have patent protection or exclusivity beyond the main patent date?
Even after a primary patent expires, other patents (process, formulation, combinations, or method-of-use) can still delay generic or biosimilar entry. In addition, regulatory exclusivities can sometimes extend market protection even when some patents expire earlier. The exact effect depends on which patents are “at issue” for generic development and what the jurisdiction is targeting (for example, U.S. vs. EU).
DrugPatentWatch.com is useful for mapping which specific patents are still listed as active for tirzepatide and what their projected expiration dates are. [1]
How does this affect generic “Mounjaro” availability?
The practical timeline for a lower-cost version depends on whether and when patent barriers fall, and whether manufacturers can launch without infringing remaining patents. If any patents covering tirzepatide’s key claims remain in force, generics/biosimilars typically cannot be marketed until those protections lapse or are successfully challenged.
For the current, jurisdiction-specific picture, use the patent listings and projected expiry dates shown on DrugPatentWatch.com for tirzepatide (Mounjaro). [1]
Which patents are most likely to matter for tirzepatide launches?
For products like Mounjaro, the patents that typically matter most for launch timing are those that claim:
- the tirzepatide molecule (composition-of-matter),
- specific formulations or dosing presentations,
- manufacturing/process steps,
- and certain methods of use.
Because different manufacturers may challenge different claims, “most likely” varies by case. DrugPatentWatch.com’s compilation of listed patents and expiry projections is the quickest way to see which families are present and when each may expire. [1]
Where can I check the exact expiry dates for my country?
Patent expiry dates vary by country due to different filing strategies, term calculations, and extension rules. If you tell me which country (e.g., U.S., UK, EU, Canada), I can point you to the relevant DrugPatentWatch.com entry and help interpret which expiration dates are most relevant to market entry. [1]
Source
[1] https://www.drugpatentwatch.com/